Interpreting pleural fluid results

被引：39

作者：

Mercer, Rachel M. ^{[1
,2
]}

Corcoran, John P. ^{[3
]}

Porcel, Jose M. ^{[4
]}

Rahman, Najib M. ^{[2
,5
]}

Psallidas, Ioannis ^{[1
,2
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Oxford Univ Hosp NHS Trust, Oxford, England

[3] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England

[4] Arnau de Vilanova Univ Hosp, Med, Lleida, Spain

[5] Univ Oxford, Resp Med, Oxford, England

来源：

CLINICAL MEDICINE | 2019年 / 19卷 / 03期

关键词：

Pleural effusion; pleural infection; malignant pleural effusion; biomarkers; TUMOR-MARKERS; EFFUSIONS; DIAGNOSIS; PREVALENCE; ACCURACY;

D O I：

10.7861/clinmedicine.19-3-213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Interpreting pleural fluid results correctly requires an awareness of the possible aetiologies of a pleural effusion and an understanding of the reliability of the outcome of each investigation. All results must be interpreted within each different clinical context and knowledge of the pitfalls for each test is necessary when the diagnosis is unclear. This review aims to discuss the common aetiologies of a pleural effusion and some of the pitfalls in interpretation that can occur when the diagnosis is unclear.

引用

页码：213 / 217

页数：5

共 46 条

[1] CYTOLOGIC AND BACTERIOLOGICAL ANALYSIS OF FLUID AND PLEURAL BIOPSY SPECIMENS WITH COPES NEEDLE - STUDY OF 414 PATIENTS [J].

BUENO, CE ;

CLEMENTE, MG ;

CASTRO, BC ;

MARTIN, LM ;

RAMOS, SR ;

PANIZO, AG ;

GLEZRIO, JM .

ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (06) :1190-1194

[2] Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score [J].

Clive, Amelia O. ;

Kahan, Brennan C. ;

Hooper, Clare E. ;

Bhatnagar, Rahul ;

Morley, Anna J. ;

Zahan-Evans, Natalie ;

Bintcliffe, Oliver J. ;

Boshuizen, Rogier C. ;

Fysh, Edward T. H. ;

Tobin, Claire L. ;

Medford, Andrew R. L. ;

Harvey, John E. ;

van den Heuvel, Michel M. ;

Lee, Y. C. Gary ;

Maskell, Nick A. .

THORAX, 2014, 69 (12) :1098-1104

[3] Pleural infection: past, present, and future directions [J].

Corcoran, John P. ;

Wrightson, John M. ;

Belcher, Elizabeth ;

DeCamp, Malcolm M. ;

Feller-Kopman, David ;

Rahman, Najib M. .

LANCET RESPIRATORY MEDICINE, 2015, 3 (07) :563-577

[4]

Davies H. E., 2010, THORAX S2, V65, pii41

[5] Diagnostic tools in tuberculous pleurisy: a direct comparative study [J].

Diacon, AH ;

Van de Wal, BW ;

Wyser, C ;

Smedema, JP ;

Bezuidenhout, J ;

Bolliger, CT ;

Walzl, G .

EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (04) :589-591

[6] Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation [J].

Drent, M ;

Cobben, NAM ;

Henderson, RF ;

Wouters, EFM ;

vanDieijenVisser, M .

EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1736-1742

[7] Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers [J].

Duffy, Michael J. .

MEDICAL PRINCIPLES AND PRACTICE, 2013, 22 (01) :4-11

[8]

GARCIA LW, 1994, MODERN PATHOL, V7, P665

[9] Urinothorax: a new approach [J].

Garcia-Pachon, Eduardo ;

Romero, Santiago .

CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (04) :259-263

[10] Diagnosis and treatment of tuberculous pleural effusion in 2006 [J].

Gopi, Arun ;

Madhavan, Sethu M. ;

Sharma, Surendra K. ;

Sahn, Steven A. .

CHEST, 2007, 131 (03) :880-889

← 1 2 3 4 5 →